Israel - English - Ministry of Health

masrouji company ltd - cefazolin as sodium 500 mg/vial - powder for solution for injection - cefazolin - treatment of serious infections caused by susceptible organisms and also perioperatively for prophylaxis. treatment respiratory tract: respiratory tract infections due to streptococcus pneumoniae (formerly diplococcus pneumoniae) klebsiella species haemophilus influenzae staphylococcus aureus (penicillin-sensitive and penicillin-resistant) and group a b - hemolytic streptococci. cefazolin is effective in the eradication of streptococci from the nasopharynx. however data establishing the efficacy of cefazolin in the subsequent prevention of rheumatic fever are not available at present. urinary tract: infections due to escherichia coli klebsiella species proteus mirabilis and some strains of enterobacter and enterococci. skin and skin structure: -hemolytic beta infections due to staphylococcus aureus (penicillin-sensitive and penicillin-resistant) group a streptococci and other strains of streptococci. biliary tract: infections due to escherichia coli various strains of streptococci proteus mirabilis klebsiella

Israel - English - Ministry of Health

masrouji co, ltd - somatropin recombinant - solution for injection - somatropin recombinant 5 mg / 1.5 ml - somatropin - children: short stature due to inadequate or failed secretion of pituitary growth hormone or turner`s syndrome. short stature in children with renal insufficiency. growth disturbance (height sds<2.5 and parenteral adjusted height sds < -1) in short children born sga (sga - small for gestational age i.e. born small in relation to the length of the fetus development) with a birth weight and/or length < 2 sd who failed to show catch up growth (hv sds < 0 during the last year) by 4 years of age or later. prader willi syndrome (pws) for improvement of growth and body composition. adults: for adults who have suffered from growth-hormone deficiency since childhood. for adults who have acquired growth hormone deficiency due to a pituitary pathology causing hypopituitarism.

Israel - English - Ministry of Health

masrouji co, ltd - cefadroxil as monohydrate - suspension - cefadroxil as monohydrate 250 mg / 5 ml - treatment of the following infections caused by cefadroxil-susceptible organisms when an oral therapy is indicated: - streptococal pharyngitis and tonsillitis - bronchopneumonia, bacterial pneumonia- uncomplicated urinary tract infections: pyelonephritis, cystitis- skin and soft tissue infections: abscesses, furunculosis, impetigo, erysipelas, pyoderma, lymphadenitis

Israel - English - Ministry of Health

masrouji co, ltd - cefadroxil as monohydrate - capsules - cefadroxil as monohydrate 500 mg - cefadroxil - treatment of the following infections caused by cefadroxil-susceptible organisms when an oral therapy is indicated: - streptococal pharyngitis and tonsillitis - bronchopneumonia, bacterial pneumonia- uncomplicated urinary tract infections: pyelonephritis, cystitis- skin and soft tissue infections: abscesses, furunculosis, impetigo, erysipelas, pyoderma, lymphadenitis

United Arab Emirates - English - MOHAP (Ministry of Health & Prevention) - وزارة الصحة ووقاية المجتمع.الإمارات

iyad masrouji drug store l.l.c united states of america - 30’s plastic bottle - capsule - combination - nutrition , blood-vitamins

Jordan - English - JFDA (Jordan Food & Drug Administration - المؤسسة العامة للغذاء والدواء)

مستودع ادوية مسروجي - masrouji drug store - bisoprolol fumarate 10.00 mg/1 tab - 10.00 mg/1 tab

Jordan - English - JFDA (Jordan Food & Drug Administration - المؤسسة العامة للغذاء والدواء)

مستودع ادوية مسروجي - masrouji drug store - bisoprolol fumarate 5.00 mg/1 tab - 5.00 mg/1 tab

Jordan - English - JFDA (Jordan Food & Drug Administration - المؤسسة العامة للغذاء والدواء)

مستودع ادوية مسروجي - masrouji drug store - sitagliptin phosphate monohydrate 128.5 mg - 128.5 mg

Jordan - English - JFDA (Jordan Food & Drug Administration - المؤسسة العامة للغذاء والدواء)

مستودع ادوية مسروجي - masrouji drug store - cabergoline 0.54 mg/1 tab - 0.54 mg/1 tab

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

mawdsley-brooks & company ltd - dexamethasone - eye drops - 1mg/1ml